Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-022460

CHIEF OPERATING OFFICER sold 16,200 shares at an average $33.77 ($547,141)

  • CHIEF OPERATING OFFICER acquired 6,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-08-18 Option exercise 10b5-1 +6,500 $8.83 $57,395 56,415 D: show line 1 in the form
Tessari Eben CHIEF OPERATING OFFICER 2025-08-18 Sale 10b5-1 −16,100 $33.77 $543,697 40,315 D: show line 2 in the form
Tessari Eben CHIEF OPERATING OFFICER 2025-08-18 Sale 10b5-1 −100 $34.44 $3,444 40,215 D: show line 3 in the form
Open-market sales · 16,200 sh · avg $33.77 · $547,141

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-08-18 Option exercise · Share Option 10b5-1 −6,500 25,500 D: show line 4 in the form
Loading xslF345X05/form4-08202025_080850.xml…